
Click image to enlarge
CMVictory Trial is a clinical trial for an investigational vaccine to protect against CMV (Cytomegalovirus) infection. This clinical trial is sponsored by Moderna. Moderna is studying mRNA-1647, an investigational vaccine, to understand whether it can help your immune system protect against cytomegalovirus (CMV). The purpose of this study is to:
- Evaluate the safety and efficacy of investigational vaccine (not yet been approved by FDA), mRNA-1647 against CMV.
- Evaluate the safety of the vaccine in women who test positive prior exposure to CMV.
What is CMV?
Cytomegalovirus, shortened to CMV, is a leading cause of birth defects around the world. CMV is a common viral infection that usually goes unnoticed or only causes mild symptoms in most people. But if a woman becomes infected with CMV while she is pregnant, she can pass the infection to her unborn baby. This can cause her child to suffer long-term disability due to birth defects, including hearing loss, or even death in very severe cases. Currently, there is no approved vaccine against CMV. CMV is the #1 infection that causes birth defects in the U.S. and one of the most common infectious causes of birth defects globally.
This is your chance to help!!
- You must be biological female between the age of 16-40
- You must be in good health
- You must have close contact with at least one child 5 years of age or younger for at least 8 hours a week
- You must be Not Pregnant or planning on becoming pregnant within the next 9 months.